(Q50635567)

17 March 2018

title

GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells. (English)

1 reference

17 March 2018

0 references

1 reference

1 reference

Mei-Ling Liu

1

1 reference

17 March 2018

Peng Zheng

2

1 reference

17 March 2018

Zhao Liu

3

1 reference

17 March 2018

Yi Xu

4

1 reference

17 March 2018

Jun Mu

5

1 reference

17 March 2018

Jing Guo

6

1 reference

17 March 2018

Ting Huang

7

1 reference

17 March 2018

Hua-Qing Meng

8

1 reference

17 March 2018

Peng Xie

9

1 reference

17 March 2018

publication date

1 July 2014

1 reference

17 March 2018

published in

Molecular BioSystems

1 reference

17 March 2018

volume

10

1 reference

17 March 2018

issue

9

1 reference

17 March 2018

page(s)

2398-2406

1 reference

17 March 2018

A systematic review of the prevalence of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Revisiting the diagnosis of schizophrenia: where have we been and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Gas chromatography/mass spectrometry in metabolic profiling of biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Plasma metabonomics as a novel diagnostic approach for major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Identification and validation of urinary metabolite biomarkers for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Comprehensive two-dimensional gas chromatography in metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

GC-MS-based urine metabolic profiling of autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Lymphocytes as a neural probe: potential for studying psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Evaluating the comparability of gene expression in blood and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Blood mononuclear cell gene expression signature of postpartum depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

TagFinder for the quantitative analysis of gas chromatography--mass spectrometry (GC-MS)-based metabolite profiling experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Orthogonal projections to latent structures (O-PLS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Analysis of metabolomic data using support vector machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

The use of the area under the ROC curve in the evaluation of machine learning algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

The neurodevelopmental hypothesis of schizophrenia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Immune involvement in schizophrenia and autism: etiology, pathology and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Metabolome in schizophrenia and other psychotic disorders: a general population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Metabolomic analysis reveals metabolic disturbance in the cortex and hippocampus of subchronic MK-801 treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Meta-analysis of oxidative stress in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Plasma total antioxidant status and cognitive impairments in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Free radicals, antioxidant defense systems, and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Minireview: New Roles for Peripheral Dopamine on Metabolic Control and Tumor Growth: Let’s Seek the Balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

The dopamine hypothesis of schizophrenia: version III--the final common pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4MB00157E

21 January 2018

Identifiers

DOI

10.1039/C4MB00157E

1 reference

17 March 2018

1 reference

17 March 2018